Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.37 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.37 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27903814 | 1.00 | DNM1 (0.48) | DNM1TSHRTHRBLPAR1LPAR3 | |
| SCHEMBL8585436 | 0.98 | DNM1 (0.45) | DNM1TSHRTHRBLPAR1LPAR3 | |
| SCHEMBL9335227 | 0.90 | — | — | |
| SCHEMBL19076 | 0.90 | — | — | |
| SCHEMBL8530071 | 0.87 | HTT (0.50) | DNM1TSHRTHRBLPAR1LPAR3 | |
| SCHEMBL11674529 | 0.84 | DNM1 (0.47) | DNM1TSHRTHRBLPAR1LPAR3 | |
| SCHEMBL9122946 | 0.84 | DNM1 (0.47) | DNM1TSHRTHRBLPAR1LPAR3 | |
| SCHEMBL5170400 | 0.84 | DNM1 (0.47) | DNM1TSHRTHRBLPAR1LPAR3 | |
| SCHEMBL10529880 | 0.84 | DNM1 (0.47) | DNM1TSHRTHRBLPAR1LPAR3 | |
| SCHEMBL11672939 | 0.84 | DNM1 (0.47) | DNM1TSHRTHRBLPAR1LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210353555-A1 | NANOPARTICLES BASED ON OPTIONALLY ALKOXYLATED POLY(ALKYL CYANOACRYLATES) HAVING A DEFINED DEGREE OF POLYMERIZATION | AbbVie Deutschland GmbH & Co. KG (DE) | 2021-11-18 | — | — | US | disclosed |
| EP-3377110-B1 | NANOPARTICLES BASED ON OPTIONALLY ALKOXYLATED POLY(ALKYL CYANOACRYLATES) HAVING A DEFINED DEGREE OF POLYMERIZATION | ABBVIE DEUTSCHLAND (DE) | 2021-01-06 | — | — | EP | disclosed |
| US-20180325833-A1 | NANOPARTICLES BASED ON OPTIONALLY ALKOXYLATED POLY(ALKYL CYANOACRYLATES) HAVING A DEFINED DEGREE OF POLYMERIZATION | AbbVie Deutschland GmbH & Co. KG (DE) | 2018-11-15 | — | — | US | disclosed |
| EP-3377110-A1 | NANOPARTICLES BASED ON OPTIONALLY ALKOXYLATED POLY(ALKYL CYANOACRYLATES) HAVING A DEFINED DEGREE OF POLYMERIZATION | AbbVie Deutschland GmbH & Co. KG (DE) | 2018-09-26 | — | — | EP | disclosed |
| EP-0669386-B1 | CYANOACRYLATE ADHESIVE COMPOSITION | TOA GOSEI CHEM IND (JP) | 1998-03-11 | — | — | EP | disclosed |
| US-5536799-A | DIPENTAERYTHRITOL POLYACRYLATE | TOAGOSEI CO., LTD. (JP) | 1996-07-16 | — | — | US | disclosed |
| EP-0669386-A1 | CYANOACRYLATE ADHESIVE COMPOSITION | TOAGOSEI CHEMICAL INDUSTRIAL CO., LTD. (JP) | 1995-08-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180325833-A1 | NANOPARTICLES BASED ON OPTIONALLY ALKOXYLATED POLY(ALKYL CYANOACRYLATES) HAVING A DEFINED DEGREE OF POLYMERIZATION | CLTA, ACMSD, ALKBH3 | DNM1 3826/4885TSHR 4883/4885THRB 4871/4885 |
| US-20210353555-A1 | NANOPARTICLES BASED ON OPTIONALLY ALKOXYLATED POLY(ALKYL CYANOACRYLATES) HAVING A DEFINED DEGREE OF POLYMERIZATION | CLTA, ACMSD, ALKBH3 | DNM1 3826/4885TSHR 4883/4885THRB 4871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.